Data presented as part of a poster at the SITC 2024 ConferenceSOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics ...

JMP Securities analyst Silvan Tuerkcan has reiterated their bullish stance on VOR stock, giving a Buy rating on November 8. Silvan ...

HC Wainwright reaffirmed their buy rating on shares of Vor Biopharma (NYSE:VOR – Free Report) in a research note issued to investors on Friday,Benzinga reports. The firm currently has a $17.50 price ...

Stephens initiates coverage on ADC Therapeutics (ADCT), highlighting Zynlonta's potential in second-line DLBCL and a ...

The Hematological Genetics lab is led by Drs Outi Kilpivaara (geneticist) and Ulla Wartiovaara-Kautto (clinical hematologist). Our research stems from the intriguing curiosity towards mechanisms of ...

A PA Student used his experience in the military, and his own health journal, to help other veterans apply and receive ...

Induction chemotherapy shows significant improvements for survival in patients with locally advanced cervical cancer.

Fintel reports that on November 8, 2024, Stephens & Co. initiated coverage of ADC Therapeutics (NYSE:ADCT) with a Overweight ...

While there is no REMS program required for obe-cel, there is a boxed warning for CRS, neurologic toxicities, and secondary ...

The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).

A disease historically associated with malnourishment on sailing vessels may have a new, modern culprit: Bariatric surgery.

Q3 2024 Earnings Call Transcript November 7, 2024 Geron Corporation beats earnings expectations. Reported EPS is $-0.04, ...